Composition and History
SMOFlipid
Omegaven
Competitor Lipids
Intralipid
100

Primary Metabolites of Omega-3 fatty acids

EPA - Eicosapentanoic Acid

DHA - Docosahexanoic Acid

100

concentrations of individual lipid sources in SMOF

Soy 30%

MCT 30%

Olive 25%

Fish Oil 15%

100

Can Omegaven be used as a sole source of IVLE in patients receiving parenteral nutrition

No 

It doesn't contain the EFAs humans require

100

composition of ClinOleic

80% Olive oil

20% Soybean oil

100

Composition of Intralipid

100% Soybean oil

200

Name the two essential fatty acids that humans require exogenously.

1. Linoleic Acid (Omega 6) - vegetable oil, nuts, seeds

2. Alpha Linolenic Acid (Omega 3) - walnuts, chia seeds

200

SMOFlipid is indicated in Neonates, Paediatric and Adult populations

TRUE OR FALSE

TRUE

200

Omegaven can be added to other IVLEs to ensure omega-3 provision. 

TRUE OR FALSE?

True

1 standard dose is 100ml which is 10g FO. However, achieving an optimal omega6:omega3 ratio in this scenario depends on the dose of Omegaven and total volume of lipid it is being added to. 

200
The omega 6:omega 3 ratio of ClinOleic

9:1

recommendation is 4:1 - 2:1

SMOFlipid ratio is ~2.5:1

200

Current and future packaging

Currently Glass bottles

Moving to plastic bags 

300

How are Medium Chain Triglycerides (MCTs) absorbed differently to long chain triglycerides (LCTs)?

1. MCTs can be absorbed directly into the bloodstream from the GI tract without need for bile salts

2. MCTs can enter mitochondria with minimal reliance on the carnitine transport system

300

Explain why Soybean oil remains an important component in SMOFLipid even though it is recognised that the precursors for pro-inflammatory mediators are derived from Omega 6 FA. 

- Essential Fatty Acid delivery 

- Linoleic and alpha linolenic acid not produced endogenously.

300

Omegaven should not be given to patients with Soy or peanut allergy as all IVLE contain soy oil. 

TRUE OR FALSE

FALSE

Omegaven is 100% Fish Oil and can be considered a safe alternative in patients with soy or peanut allergy (EFA deficiency considerations aside)

300

ClinOleic contains higher amounts of alpha tocopherol and higher amounts of phytosterols than SMOFlipid


TRUE OR FALSE

FALSE

ClinOleic contains higher amounts of Phytosterols (bad) than SMOFLipid but much lower amounts of alpha tocopherol (vitamin E - anti-oxidant, good)

300

List two main uses in developed countries 

- in treating local anaesthetic toxicity

- IVF (potentially suppressing NK cell activity)

400

Briefly explain the history of IV lipid emulsions

- 1960s 100% SO, Intralipid

-1980s MCT:LCT, Structolipid, Lipovonoes

-1990s OO:SO, ClinOleic

-2000s SO:MCT:OO:FO, SMOF, Omegaven

400

Name 2 main reasons why SMOFLipid is chosen in neonates

1. DHA supplementation - visual, neural and mental development

2. Favourable FA pattern - more similar to human cord blood & breast milk than other IVLE

others: high energy reqs, improved antioxidant status, liver parameters, weight gain, well tolerated

400

Phytosterol content in mg/l

0


that was a trick question. LOL

400

ClinOleic contains more Linoleic (omega-6) acid than SMOFlipid


TRUE OR FALSE

FALSE

ClinOleic contains slightly less Linoleic acid than SMOFlipid (18.5% vs 21.4%)

It also contains less alpha linolenic acid than SMOFLipid (2% vs 2.5%)

400

Omega 6: Omega 3 Ratio

7:1

500

Describe the composition of fatty acids at a molecular level. Include references to chain length and the differences between saturated, mono and poly unsaturated.

- carbon chain with methyl end and acidic end

- chain length + degree of saturation

- Short chain <C4, Medium C6-C12, long C14-C26

- no c=c is saturated, 1 c=c is mono, >1 c=c poly

500

List 4 clinical benefits of FO containing PN that studies (e.g. Pradelli, Notz) have found over non FO containing PN. 

1. Reduction in infection rate

2. Reduction in ICU LOS

3. Reduction in Hospital LOS

4. Reduction in Sepsis rate

500

Name 1 common use of Omegaven in the clinical setting

Rescue therapy for paediatric liver disease, particularly IFALD. 

Note: Fresenius-Kabi still considers this off-label use. Omegaven should not be used in premature infants, newborns, infants and children due to limited experience. 

500
name 3 of the main promotionl arguments of ClinOleic

- source of EFA to prevent deficiency

- immune & inflammatory neutral

- lower amounts of phytosterols than SO and MCT:LCT based IVLE

- Oleic acid - less susceptible to lipid peroxidation

- well tolerated in critically ill patients

500

Phytosterol Content in mg/l

348 +/-33

M
e
n
u